Mission Wealth Management
GILD icon

Mission Wealth Management’s Gilead Sciences GILD Stock Holding History

Mission Wealth Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-7,000
Closed -$438K – 317
2018
Q4 		$438K Buy
+7,000
New +$489K 0.06% 165

Other funds holding GILD

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Confluence Investment Management
Confluence Investment Management St. Louis, Missouri $5.97B AUM 5.11% 1-Year Est. Return
Bailard
Bailard Foster City, California $4.94B AUM 25.15% 1-Year Est. Return
Fjarde Ap-fonden
Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return
MN Services Vermogensbeheer
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
Czech National Bank
Czech National Bank Prague, Czech Republic $18.9B AUM 36.24% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.95B AUM 16% 1-Year Est. Return
IFM Investors
IFM Investors Melbourne, Australia $16B AUM 33.69% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
CA
CapWealth Advisors Franklin, Tennessee $1.32B AUM 21.6% 1-Year Est. Return

Mission Wealth Management's GILD Position: Q3 2026 in Review

Mission Wealth Management reduced its Gilead Sciences (GILD) stake by 38% in Q3 2026, selling an estimated $892K and leaving 10,519 shares worth $1.57M. The position accounts for 0.02% of the portfolio, ranked #300.

Mission Wealth Management first reported a position in GILD in Q2 2015 and has held it in 46 quarters since. The position peaked at $3.06M in Q3 2019. 303 funds tracked by Wall St. Rank hold GILD as of Q3 2026.

  • Mission Wealth Management held 10,519 shares of Gilead Sciences worth $1.57M as of Q3 2026.
  • Mission Wealth Management sold 6,360 Gilead Sciences shares in Q3 2026, an estimated $892K.
  • Gilead Sciences made up 0.02% of Mission Wealth Management's portfolio in Q3 2026, its #300 holding.
  • Mission Wealth Management first reported a position in Gilead Sciences in Q2 2015 and has held it in 46 quarters since.
  • Mission Wealth Management's Gilead Sciences position peaked at $3.06M in Q3 2019.
  • 303 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2026.

Based on Mission Wealth Management's 13F filing for Q3 2026, filed 15 Oct 2026.